The innate recognition of fungal pathogens is mediated by a variety of pattern recognition receptors (PRRs), although much interest has focussed on the Toll-like Receptors (TLR). More recently, however, there is growing appreciation that the non-TLRs have a major role in the control of infection with these organisms. One such molecule is Dectin-1, a C-type lectin-like receptor which induces numerous cellular responses upon recognition of fungal b-glucans. Here we review our current understanding of the functions of Dectin-1 and the underlying molecular mechanisms, as well as explore the role of this receptor in antifungal immunity.
Introduction
Opportunistic fungal pathogens have a huge impact in our society, and this has arisen as a result of modern medical practices and the increased incidence of immunocompromised individuals [1] . In healthy individuals, the control of these organisms is largely mediated by phagocytic cells of the innate immune system, including macrophages, monocytes and neutrophils. The initiation of protective responses by these cells relies on germ-line encoded receptors, the pattern recognition receptors (PRRs) [2] . These receptors facilitate the distinction between 'self' and 'non-self' through the recognition of conserved microbial components; the pathogen associated molecular patterns (PAMPs). Recognition by the PRRs leads to fungal uptake, killing and the induction of inflammatory responses, which activates and recruits other cells to the site of infection and can ultimately lead to the initiation of adaptive immunity [3] .
In the last few years, a growing number of PRRs have been implicated in antifungal immunity. Of these, much interest has focussed on the Toll-like receptors which are generally considered to be the principal receptors involved in microbial recognition and intracellular signalling (reviewed in [4] ). Although a number of TLRs, including TLR2, TLR4 and TLR9, have been implicated in the innate response to fungal infections, other 'non-TLR' receptors also play key functions (reviewed in [5] ). Of these molecules, Dectin-1, the leukocyte receptor for b-glucans, appears to play a central role. Here we will review Dectin-1 and its role in antifungal immunity, highlighting how the study of this receptor has provided novel insights into our understanding of innate immunity in general.
b-Glucan as a fungal PAMP
Despite the growing number of PRRs implicated in antifungal immunity, relatively few fungal PAMPs have been identified and nearly all of these appear to be carbohydrate-based structures found on the fungal cellwall (reviewed in [5] ). b-Glucan, however, is one of the few fungal PAMPs which is well characterized, and can comprise up to 50% of the dry weight of the cell wall. These carbohydrates consist of long linear b (1,3) linked glucose polymers, with varying degrees of b (1,6) branching, and form a strong meshwork which provides structural support and elasticity [6, 7] . bGlucans were originally thought to be located deep within the cell wall and masked by a layer of mannoproteins. Recent evidence, however, suggests that these polymers are actually displayed at the cell surface, although restricted to particular regions, such as bud scars, in certain fungal species [8Á10]. b-Glucans have also been described in plants and some bacteria, but are not found in the metazoa.
These carbohydrates have long been known to possess immune modulating activities and have been extensively studied for their anti-tumour and antiinfective activities [11] . However, much of the older literature on this topic is confusing and often contradictory, which is likely to be due to the heterogeneous nature and purity of the b-glucan preparations used as well as a lack of an understanding of the underlying molecular mechanisms. In the last few years, a number of PRRs for b-glucans have been discovered, and their study has significantly advanced our understanding of the mechanisms involved in the recognition and response to these carbohydrates. To date at least four b-glucan receptors have been described, Dectin-1, lactosylceramide, complement receptor 3 (CR3) and unidentified scavenger receptor(s), and there is evidence for a role of all these receptors in the biological activity of b-glucans (for a review see [9] ). However, Dectin-1 is the major receptor for these carbohydrates on leukocytes and can trigger many of the associated cellular responses.
Identification, structure and expression of Dectin-1
Dectin-1 was originally discovered through subtractive cDNA cloning from murine dendritic cells [12] and the human homologue was identified shortly thereafter [13Á15] . Dectin-1 is a type II transmembrane protein and a member of the group V C-type lectin-like receptors [16, 17] , consisting of a single extracellular C-type lectin-like domain (CTLD), a stalk and transmembrane region, and a cytoplasmic tail containing signalling motifs (Fig. 1) . The CTLD of Dectin-1 has been crystallized and shown to be structurally similar to those of other C-type lectin-like receptors [18] . Dectin-1 is N-glycosylated and this post-translational modification contributes to the expression of the receptor at the cell surface and its function [19] . In contrast to many other C-type lectin-like receptors, Dectin-1 lacks cysteine residues in the stalk region, which are required for dimerization, and the receptor appears to be expressed, and function, as a monomer [12] . Dectin-1 is alternatively spliced in both human and mouse generating two major and a number of minor isoforms. The major isoforms differ by the presence or absence of a stalk region, and possess altered functionalities [14, 20] . Recently, a minor human isoform, which lacks the stalk and transmembrane regions (hDectin*1E), was shown to be cytoplasmic located and capable of interacting with other cytoplasmic proteins [21] . Fig. 1 Schematic representation of the structure of murine Dectin-1. Dectin-1 consists of an extra-cellular region; which includes the C-type lectin-like carbohydrate recognition domain (CRD) and stalk (which can be alternatively spliced out); a transmembrane region; and a cytoplasmic domain, containing the immunoreceptor tyrosine-based activation motif-like sequence (ITAM-like).
Dectin-1 is expressed in many tissues, particularly at portals of pathogen entry, such as the lung, but not in immune-privileged tissues, such as the eye and the brain [22, 23] . The receptor is predominantly expressed by myeloid cells, such as macrophages, monocytes, dendritic cells, neutrophils and microglia, but it is also expressed on a subpopulation of T cells [23Á25] . Furthermore, in humans, Dectin-1 is expressed by mast cells, B-cells and eosinophils [24, 26] . The highest levels of Dectin-1 expression are found on alveolar macrophages and in inflammatory cell populations in mouse, but not human [23, 24] . For reasons which are still unclear, the major isoforms show cell-type (human) and species-specific (mouse) patterns of expression [20, 24] . The levels of Dectin-1 expression can be significantly influenced by cytokines and other agents, such as b-glucan, GM-CSF and dexamethasone [27, 28] and, interestingly, there is a clear correlation between the effects of many of these agents on antifungal immunity and their effects on Dectin-1 expression and function [27] .
Ligands of Dectin-1
Dectin-1 was identified as a b-glucan receptor following a functional screen of a macrophage-derived cDNA expression library for receptors for the fungal-derived b-glucan-rich particle, zymosan [29, 30] . Dectin-1 recognizes particulate and soluble b-glucans in a cationindependent manner from fungi, plants and bacteria, and is the primary receptor for these carbohydrates on leukocytes [30Á33]. Detailed biochemical characterization of the specificity of Dectin-1 has shown that the receptor recognizes (1,3)-linked b-glucans, and that the affinity of these interactions, which can be exceedingly high, is influenced by the degree of branching and polymer length [30, 34, 35] . Dectin-1 does not recognize other linkages, monomers or short b(1,3)-linked oligosaccharides and the minimum unit recognized is an octosaccharide. However, Dectin-1 can recognize mycobacteria, which do not express b-glucans, suggesting that there are other, so far unidentified, exogenous ligands for this receptor [36, 37] .
Although best known for its ability to recognize bglucans, Dectin-1 was originally identified as a receptor for T cells and may therefore also recognize an endogenous ligand [12, 14] . However, there has been little progress in identifying the nature and physiological significance of this T-cell ligand. Dectin-1 is most similar to the 'non-classical' C-type lectin-like receptors which typically recognize proteinacious ligands, such as MHC molecules [38] . Indeed the gene encoding Dectin-1 is located within a large cluster of these molecules, the natural killer gene complex, located on chromosome 6 in mouse and chromosome 12 in human. It is possible that Dectin-1 recognizes a proteinacious endogenous ligand, a suggestion which is supported by evidence that the T-cell ligand is sensitive to proteases [12] . The interaction of Dectin-1 with its endogenous ligand has been proposed to stimulate the activation and proliferation of T-cells [12, 39] . Interestingly, the recognition of T-cells is not inhibitable by b-glucans, suggesting that Dectin-1 may have two ligand-binding sites [14] .
Dectin-1 mediated intracellular signalling and cellular responses
The cytoplasmic tail of Dectin-1 contains a sequence (Y XXX I/L X7 Y XX L) which strongly resembles the immunoreceptor tyrosine-based activation motifs (ITAM) found in several other activation receptors, such as DAP12 and F C g [40, 41] . Through this motif Dectin-1 can induce intracellular signalling resulting in a variety of cellular responses, which have been mostly characterized using zymosan. These responses include the respiratory burst [42] , PLA2 and COX activation [43] , phagocytosis, endocytosis [44] , and the induction of cytokines and chemokines, including IL-23, IL-2, IL-6, TNF-a,IL-10 and MIP-2 [42,45Á48] . While signalling from Dectin-1 is sufficient for many of these responses, others, such as the induction of pro-inflammatory cytokines, requires collaborative signalling with the TLRs [42, 46, 49] . Dectin-1 was the first example of a non-TLR signalling PRR and also the first example of a receptor which could collaborate with the TLRs.
Dectin-1 mediated intracellular signalling is not fully understood, but appears to involve multiple pathways. Upon ligand binding, the ITAM-like motif of Dectin-1 becomes tyrosine phosphorylated [42] , presumably by Src family kinases [50] , but unlike traditional ITAMs, only the membrane proximal YxxL of Dectin-1 is required for signalling [44] . This sequence is sufficient to recruit Syk kinase [33, 47, 51] , providing the first example of a single tyrosine-based sequence that could recruit Syk. Like other activation receptors, Syk is a central kinase involved in inducing most of the Dectin-1-mediated cellular responses, including cytokine production and the respiratory burst [33, 45, 47] . Downstream signalling through this pathway involves ERK [52] , CARD9 [53] , and NFAT [54] . The Syk pathway is also required for collaborative signalling with the TLRs, but the mechanism underlying these collaborative responses are unknown [49] . Dectin-1 can trigger Syk-independent pathways, such as phagocytosis in macrophages [44] , but the signalling mechanisms involved are largely uncharacterized.
The role of Dectin-1 in antifungal immunity
Through its specificity for b-glucans, Dectin-1 can recognize a number of fungal species including Coccidioides [55] , Saccharomyces [46] , Aspergillus [56Á58], Pneumocystis [48] , and Candida [46] . In vitro characterization of the interaction of these organisms with isolated primary cells and transfected cells, has demonstrated that Dectin-1 can induce a number of protective cellular responses to fungi, such as phagocytosis and killing, which is mediated, at least in part, through the induction of the respiratory burst [10, 48, 59] . These interactions also lead to the induction of numerous cytokines and chemokines, including MIP-1a, GM-CSF, G-CSF, TNFa, MIP-2, IL-1b, IL-1a, IL-23, IL-10, IL-2 and IL-6 [45Á48, 55, 56] .
While many of these cytokines promote antifungal immunity [60] , others, such as IL-10 and IL-23, are not thought to be protective. IL-10, for example, inhibits anti-fungal immune responses [61] , although this cytokine does contribute to the development of regulatory T cells [62, 63] , and these cells may be important for promoting fungal persistence and long-term immunity and for limiting inflammatory pathology [64, 65] . Another example is IL-23, which was shown to be induced by Dectin-1, contributing to the development of Th 17 adaptive responses [45] . Although this was the first example of a non-TLR PRR capable of directly coupling innate to adaptive immunity, IL-23 and Th 17 responses were recently shown to contribute to impaired antifungal immunity in mice by promoting inappropriate inflammation and negatively regulating Th 1 responses [66] . Interestingly, human memory responses to C. albicans were found to be predominantly Th 17 [67] .
Dectin-1 has been shown to play a protective role in vivo. In A. fumigatus infections in mice, for example, blockage of Dectin-1 function during intratracheal challenge, using a soluble inhibitor, significantly reduced inflammatory responses and increased fungal burdens in the lung [56] . Characterisation of the Dectin-1 knockout mice has also revealed a role for this receptor in antifungal immunity in vivo, although there is some confusion about the relevant importance of this receptor. In one strain, Dectin-1 deficiency resulted in defects in inflammatory responses and fungal killing leading to an enhanced susceptibility to systemic infection with C. albicans [32] . This study was supported by a similarly increased susceptibility to this pathogen that was found in mice deficient in CARD9, a downstream component of the Dectin-1 signalling pathway [53] . In contrast, another Dectin-1 deficient strain displayed no defects in resistance to infection with C. albicans [68] . However, in this mouse strain there were differences in fungal burdens during infection with P. carinii, resulting from defects in the macrophage respiratory burst [68] . More recently, this strain was also used to show that Dectin-1 was not involved in resistance to Cryptococcus neoformans [69] .
There is growing evidence that fungal pathogens may mask their b-glucan to avoid recognition by Dectin-1. In C. albicans, for example, the hyphal forms do not have surface-exposed b-glucan, and are not recognized by Dectin-1, and this may explain why hyphae do not induce protective host responses [10, 70] . Indeed, enhancing the exposure of b-glucans on the surface of this pathogen, by disrupting the mannoprotein outer layer, was shown to improve antifungal immune responses even to hyphae [71] . Similarly in A. fumigatus, swollen conidia and early germlings display b-glucan at the surface, and are recognized by Dectin-1, whereas resting conidia and hyphae do not [56Á58]. However, for this organism the immunological significance of this morphologically-related exposure of b-glucans is not clear. More recently, Histoplasma capsulatum was also shown to avoid Dectin-1-mediated immune responses by hiding its b-glucan under a layer of a-glucan [72] .
Conclusions
The discovery and characterization of Dectin-1 has furthered our understanding of the molecular mechanisms underlying the innate recognition of pathogens. Although we are still in the early days, the evidence suggests that this receptor plays an important role in antifungal immunity. However, much still needs to be done to clarify the exact role of this molecule and it is quite likely that some of the current confusion, especially with in vivo studies, results from differences in the strain of mice or pathogen used and the experimental design. Finally, there is currently no evidence for a clinical role of this receptor and studies looking for association with human disease are still lacking and warrant attention.
